CXCL8 and prostate carcinoma: Inactivation of PTEN is prevalent in prostate cancer [43] and its loss induces a selective upregulation of pro-inflammatory cytokine CXCL8 signaling that sustains the proliferation and survival of PTEN-deficient prostate epithelium [3]-[7].